LINCOLN NATIONAL CORP - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 38 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LINCOLN NATIONAL CORP ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2023$2,131
-46.7%
11,215
+8.7%
0.00%
Q2 2022$4,000
-69.2%
10,3150.0%0.00%
Q1 2022$13,0000.0%10,3150.0%0.00%
Q4 2021$13,000
-40.9%
10,315
+3.2%
0.00%
-100.0%
Q4 2019$22,00010,0000.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Corrigan Financial, Inc. 302,252$102,7660.03%
Virtu Financial LLC 13,324$50.00%
Bleakley Financial Group, LLC 80,000$27,2000.00%
Beaird Harris Wealth Management, LLC 24,400$8,2960.00%
One Day In July LLC 10,000$3,4000.00%
Cubic Asset Management, LLC 10,000$3,4000.00%
WMS Partners, LLC 18,000$6,1200.00%
Simplicity Solutions, LLC 80,000$27,2000.00%
WELLS FARGO & COMPANY/MN 3,296$1,1210.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders